Serum Apolipoprotein A-I Combined With C-Reactive Protein Serves As A Novel Prognostic Stratification System For Colorectal Cancer

References

• Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. doi:10.1002/ijc.2551621351269
   PubMed Web of Science ®Google Scholar
• Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann Surg Oncol. 2016;23(3):900–907. doi:10.1245/s10434-015-4948-726530445
   PubMed Web of Science ®Google Scholar
• Seong MK. Prognostic inflammation score in surgical patients with colorectal cancer. J Korean Med Sci. 2015;30(12):1793–1799. doi:10.3346/jkms.2015.30.12.179326713054
   PubMed Web of Science ®Google Scholar
• Jung YS, Ryu S, Chang Y, et al. Associations between parameters of glucose and lipid metabolism and risk of colorectal neoplasm. Dig Dis Sci. 2015;60(10):2996–3004. doi:10.1007/s10620-015-3713-x25986527
   PubMed Web of Science ®Google Scholar
• Luo X, Cheng C, Tan Z, et al. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76. doi:10.1186/s12943-017-0646-328399876
   PubMed Web of Science ®Google Scholar
• Chang SJ, Hou M-F, Tsai S-M, et al. The association between lipid profiles and breast cancer among Taiwanese women. Clin Chem Lab Med. 2007;45(9):1219–1223. doi:10.1515/CCLM.2007.26317663634
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao X-W, Liu D-B, et al. Lipid levels in serum and cancerous tissues of colorectal cancer patients. World J Gastroenterol. 2014;20(26):8646–8652. doi:10.3748/wjg.v20.i26.864625024621
   PubMed Web of Science ®Google Scholar
• Cruz PM, Mo H, McConathy WJ, Sabnis N, Lacko AG. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 2013;4:119. doi:10.3389/fphar.2013.0011924093019
   PubMed Web of Science ®Google Scholar
• Long J, Zhang C-J, Zhu N, et al. Lipid metabolism and carcinogenesis, cancer development. Am J Cancer Res. 2018;8(5):778–791.29888102
   PubMed Web of Science ®Google Scholar
• Jiang R, Yang ZH, Luo DH, et al. Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma. Med Oncol. 2014;31(8):80. doi:10.1007/s12032-014-0374-025023050
   PubMed Web of Science ®Google Scholar
• Zhang Z, Bast RC, Yu Y, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004;64(16):5882–5890. doi:10.1158/0008-5472.CAN-04-074615313933
   PubMed Web of Science ®Google Scholar
• Ehmann M, Felix K, Hartmann D, et al. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas. 2007;34(2):205–214. doi:10.1097/01.mpa.0000250128.57026.b217312459
   PubMed Web of Science ®Google Scholar
• Frank PG, Marcel YL. Apolipoprotein A-I: structure-function relationships. J Lipid Res. 2000;41(6):853–872.10828078
   PubMed Web of Science ®Google Scholar
• Sorci-Thomas MG, Bhat S, Thomas MJ. Activation of lecithin: cholesterolacyltransferase by HDL ApoA-I central helices. Clin Lipidol. 2009;4(1):113–124. doi:10.2217/17584299.4.1.11320582235
   PubMed Web of Science ®Google Scholar
• Huang HL, Stasyk T, Morandell S, et al. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis. 2006;27(8):1641–1650. doi:10.1002/elps.20050085716550499
   PubMed Web of Science ®Google Scholar
• Sung KC, Ryu S, Wild SH, Byrne CD. An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality. Heart. 2015;101(7):553–558. doi:10.1136/heartjnl-2014-30678425637367
   PubMed Web of Science ®Google Scholar
• de Souza JA, Vindis C, Nègre-Salvayre A, et al. Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. J Cell Mol Med. 2010;14(3):608–620. doi:10.1111/j.1582-4934.2009.00713.x19243471
   PubMed Web of Science ®Google Scholar
• Fuhrman B, Gantman A, Aviram M. Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis. Atherosclerosis. 2010;211(1):61–68. doi:10.1016/j.atherosclerosis.2010.01.02520149374
   PubMed Web of Science ®Google Scholar
• Bhattacharyya T, Nicholls SJ, Topol EJ, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA. 2008;299(11):1265–1276. doi:10.1001/jama.299.11.126518349088
   PubMed Web of Science ®Google Scholar
• Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res. 2006;4(4):221–233. doi:10.1158/1541-7786.MCR-05-026116603636
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kashima H, Wu R-C, et al. Mevalonate pathway antagonist suppresses formation of serous tubal intraepithelial carcinoma and ovarian carcinoma in mouse models. Clin Cancer Res. 2015;21(20):4652–4662. doi:10.1158/1078-0432.CCR-14-336826109099
   PubMed Web of Science ®Google Scholar
• Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science. 2013;339(6117):286–291. doi:10.1126/science.123222723329041
   PubMed Web of Science ®Google Scholar
• Zamanian-Daryoush M, Lindner D, Tallant TC, et al. The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects. J Biol Chem. 2013;288(29):21237–21252. doi:10.1074/jbc.M113.46896723720750
   PubMed Web of Science ®Google Scholar
• Kim YW, Bae SM, Lim H, et al. Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers. PLoS ONE. 2012;7(9):e44960. doi:10.1371/journal.pone.005090022970327
   PubMed Web of Science ®Google Scholar
• Tuft Stavnes H, Nymoen DA, Hetland Falkenthal TE, Kærn J, Tropé CG, Davidson B. APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival. Am J Clin Pathol. 2014;142(1):51–57. doi:10.1309/AJCPD8NBSHXRXQL724926085
   PubMed Web of Science ®Google Scholar
• Luo XL, Zhong G-Z, Hu L-Y, et al. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma. Oncotarget. 2015;6(41):44037–44048. doi:10.18632/oncotarget.582326503474
   PubMedGoogle Scholar
• van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European prospective investigation into cancer and nutrition. Gut. 2011;60(8):1094–1102. doi:10.1136/gut.2010.22501121383385
   PubMed Web of Science ®Google Scholar
• Gelfo V, Rodia MT, Pucci M, et al. A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors. Oncotarget. 2016;7(44):72167–72183. doi:10.18632/oncotarget.1235427708224
   PubMed Web of Science ®Google Scholar
• Li C, Xu Q, Chen L, Luo C, Ying J, Liu J. C-reactive protein (CRP) as a prognostic factor for colorectal cancer after surgical resection of pulmonary metastases. Bull Cancer. 2017;104(3):232–236. doi:10.1016/j.bulcan.2016.11.01628063672
   PubMed Web of Science ®Google Scholar
• Gelfo V, Mazzeschi M, Grilli G, et al. A novel role for the interleukin-1 receptor axis in resistance to anti-EGFR therapy. Cancers (Basel). 2018;10(10). doi:10.3390/cancers10110400.
   PubMed Web of Science ®Google Scholar
• Welti J, Loges S, Dimmeler S, Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest. 2013;123(8):3190–3200. doi:10.1172/JCI7021223908119
   PubMed Web of Science ®Google Scholar
• Hu T, Li LF, Shen J, Zhang L, Cho CH. Chronic inflammation and colorectal cancer: the role of vascular endothelial growth factor. Curr Pharm Des. 2015;21(21):2960–2967. doi:10.2174/138161282166615051410424426004415
   PubMed Web of Science ®Google Scholar
• Okada F, Rak JW, Croix BS, et al. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci U S A. 1998;95(7):3609–3614. doi:10.1073/pnas.95.7.36099520413
   PubMed Web of Science ®Google Scholar
• Gao F, Vasquez SX, Su F, et al. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Integr Biol (Camb). 2011;3(4):479–489. doi:10.1039/c0ib00147c21283904
   PubMed Web of Science ®Google Scholar
• Su F, Kozak KR, Imaizumi S, et al. Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci U S A. 2010;107(46):19997–20002. doi:10.1073/pnas.100901010721041624
   PubMed Web of Science ®Google Scholar
• Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016;17(3):230–240. doi:10.1038/ni.338426882261
   PubMed Web of Science ®Google Scholar
• Garcia-Anguita A, Kakourou A, Tsilidis KK. Biomarkers of inflammation and immune function and risk of colorectal cancer. Curr Colorectal Cancer Rep. 2015;11(5):250–258. doi:10.1007/s11888-015-0282-526321888
   PubMedGoogle Scholar
• Romano M, DE Francesco F, Zarantonello L, et al. From inflammation to cancer in inflammatory bowel disease: molecular perspectives. Anticancer Res. 2016;36(4):1447–1460.27069120
   PubMed Web of Science ®Google Scholar
• Erdogan S, Yilmaz FM, Yazici O, et al. Inflammation and chemerin in colorectal cancer. Tumour Biol. 2016;37(5):6337–6342. doi:10.1007/s13277-015-4483-y26628300
   PubMedGoogle Scholar
• Cahlin C, Lönnroth C, Arvidsson A, Nordgren S, Lundholm K. Growth associated proteins in tumor cells and stroma related to disease progression of colon cancer accounting for tumor tissue PGE2 content. Int J Oncol. 2008;32(4):909–918.18360718
   PubMed Web of Science ®Google Scholar
• Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007;246(6):1047–1051. doi:10.1097/SLA.0b013e318145417118043109
   PubMed Web of Science ®Google Scholar
• Navab M, Anantharamaiah GM, Reddy ST, et al. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol. 2005;25(7):1325–1331. doi:10.1161/01.ATV.0000165694.39518.9515831812
   PubMed Web of Science ®Google Scholar
• Van Lenten BJ, Wagner AC, Jung C-L, et al. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J Lipid Res. 2008;49(11):2302–2311. doi:10.1194/jlr.M800075-JLR20018621920
   PubMed Web of Science ®Google Scholar